Compound 734
Identifiers
- Canonical SMILES:
FC(F)(F)S(=O)(=O)c1cc(ccc1N[C@H](CCN1CCOCC1)CSc1ccccc1)S(=O)(=O)Nc1ncnc2CN(CCc12)C1CCN(Cc2ccccc2-c2ccc(Cl)cc2)CC1
- InChi:
InChI=1S/C46H51ClF3N7O5S3/c47-35-12-10-33(11-13-35)40-9-5-4-6-34(40)29-56-21-17-37(18-22-56)57-23-19-41-43(30-57)51-32-52-45(41)54-65(60,61)39-14-15-42(44(28-39)64(58,59)46(48,49)50)53-36(16-20-55-24-26-62-27-25-55)31-63-38-7-2-1-3-8-38/h1-15,28,32,36-37,53H,16-27,29-31H2,(H,51,52,54)/t36-/m1/s1
- InChiKey:
JDBVJFFIOIPKTL-PSXMRANNSA-N
External links
88540488 |
External search
Bibliography (1)
Publication | Name |
---|---|
Karen Miller-Moslin, Bakary-Barry Toure, Michael Scott Visser, Naeem Yusuff, Novartis Ag. . Sulfonamides as inhibitors of bcl-2 family proteins for the treatment of cancer None. | 9 |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.84 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 969.28 g/mol | |||
HBA | 12 | |||
HBD | 2 | |||
HBA + HBD | 14 | |||
AlogP | 6.37 | |||
TPSA | 137.07 | |||
RB | 16 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
WO2011029842 | 9 | BCL2 P10415 |
|
Biochemical assay | Surface Plasmon Resonance | pIC50 (half maximal inhibitory concentration, -log10) | 6.84 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5256 | Navitoclax | DB12340 | |
0.4271 | GDC-0349 | DB13072 | |
0.3894 | Quinupristin | DB01369 | |
0.3851 | N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE | DB06899 | |
0.3785 | Sulfaisodimidine | DB13283 | |
0.3695 | Presatovir | DB12165 | |
0.3652 | N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE | DB07800 | |
0.3648 | Omidenepag isopropyl | DB15071 | |
0.3636 | CH-5132799 | DB13051 | |
0.3620 | Bleomycin | DB00290 | |
0.3598 | Sparsentan | DB12548 | |
0.3579 | Talotrexin | DB06178 | |
0.3546 | Elobixibat | DB12486 | |
0.3534 | Sulfametomidine | DB13485 | |
0.3510 | Satavaptan | DB14923 |